Canan Eroğlu Güneş
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Canan Eroğlu Güneş has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Ercan Kurar
Department of Medical Biology, Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey
12 shared publications - Fatma Seçer Çelik
Department of Medical Biology and Genetics, Faculty of Medicine, Ankara Medipol University, 06050 Ankara, Turkey
6 shared publications - Sedef Akçaalan
Department of Medical Biology, Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey
5 shared publications - Mücahit Seçme
Department of Medical Biology, Faculty of Medicine, Ordu University, Ordu, Türkiye
2 shared publications - Ali Celik
Department of Thoracic Surgery, Gazi University Faculty of Medicine, Ankara, Türkiye
1 shared publication - Aysu Şen
Necmettin Erbakan University, Faculty of Medicine, Department of Physiology, Konya, Türkiye
1 shared publication
Latest Publications
- 29 September 2026
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 269
Antidepressant potential of agmatine: Effects on hypothalamic neurogenesis in rats with depressive behavior
- 29 September 2026
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 269
Antidepressant potential of agmatine: Effects on hypothalamic neurogenesis in rats with depressive behavior
- Open Access
- 17 June 2026
- Published by Springer Nature in 3 Biotech
- Vol. 16 (7) , 279
XBP1 gene silencing augments quercetin-induced apoptosis and anti-metastatic activity in breast cancer cell lines
This study investigated the combined effects of quercetin (Que) and shRNA-mediated XBP1 silencing on the MCF7 and MDA-MB-231 breast cancer cell lines. Que was selected because of its well-known anticancer effects. XBP1, on the other hand, was targeted because it has been reported to play a critical role in the progression of breast cancer and in stress-adaptive signaling. Cell viability and colony formation assays showed that Que and XBP1 silencing reduced cell growth, with the combined treatment producing a more pronounced inhibitory effect. In both cell lines, the combined treatment was associated with increased expression of apoptosis-related markers, including CASP3, CASP8 and CASP9, supporting a pro-apoptotic response. In addition, treatment-related changes were observed in EMT-associated markers, including increased CDH1 expression and decreased CDH2 expression, suggesting modulation of EMT-related molecular characteristics. Overall, these findings indicate that the combined application of XBP1 silencing and Que exerts anti-proliferative and apoptosis-associated effects on breast cancer cells and may also influence EMT-related molecular pathways. These results support the potential of combining RNAi-based approaches with plant-derived natural compounds as a therapeutic strategy for breast cancer.
- 17 June 2026
- Published by Springer Nature in 3 Biotech
- Vol. 16 (7) , 279
Open AccessXBP1 gene silencing augments quercetin-induced apoptosis and anti-metastatic activity in breast cancer cell lines
This study investigated the combined effects of quercetin (Que) and shRNA-mediated XBP1 silencing on the MCF7 and MDA-MB-231 breast cancer cell lines. Que was selected because of its well-known anticancer effects. XBP1, on the other hand, was targeted because it has been reported to play a critical role in the progression of breast cancer and in stress-adaptive signaling. Cell viability and colony formation assays showed that Que and XBP1 silencing reduced cell growth, with the combined treatment producing a more pronounced inhibitory effect. In both cell lines, the combined treatment was associated with increased expression of apoptosis-related markers, including CASP3, CASP8 and CASP9, supporting a pro-apoptotic response. In addition, treatment-related changes were observed in EMT-associated markers, including increased CDH1 expression and decreased CDH2 expression, suggesting modulation of EMT-related molecular characteristics. Overall, these findings indicate that the combined application of XBP1 silencing and Que exerts anti-proliferative and apoptosis-associated effects on breast cancer cells and may also influence EMT-related molecular pathways. These results support the potential of combining RNAi-based approaches with plant-derived natural compounds as a therapeutic strategy for breast cancer.
- 31 December 2025
- Published by Necmettin Erbakan University in Necmettin Erbakan Üniversitesi Fen ve Mühendislik Bilimleri Dergisi
- Vol. 7 (3) , 372-381
Oleandrin Downregulates Toll-Like Receptor Pathway Genes in Human Endometrial Carcinoma Cells
Endometrial kanser, endometriyal dokularda kötü huylu hücrelerin gelişiminden kaynaklanır ve dünya genelinde kadınlar arasında altıncı en yaygın kanser türüdür. Doğuştan gelen bağışıklık sisteminin bir bileşeni olan Toll benzeri reseptörler (TLR’ler), patojenlerin tanınmasında kritik bir işlev üstlenir. Önceki araştırmalar, TLR’ler ile farklı kanser türleri arasında bir ilişki olduğunu ve TLR ekspresyonunun kanser hücrelerinde progresyon, apoptoz ve hayatta kalma ile ilişkili olduğunu göstermiştir. Apocynaceae familyasından olan Nerium oleander L., geleneksel olarak çeşitli hastalıkların tedavisinde kullanılmıştır. N. oleander’in yaprakları ve tohumlarından elde edilen oleandrin bileşiği, çeşitli insan kanser hücrelerinin büyümesini baskıladığı gösterilmiştir. Bu çalışma, oleandrinin Ishikawa insan endometrial karsinom hücrelerinde TLR yolağı genleri üzerine etkisini incelemeyi amaçlamıştır. Oleandrin uygulamasının ardından, XTT proliferasyon testi 24., 48. ve 72. saatlerde gerçekleştirilmiştir. IC50 değeri 48. saat için 75,3 nM olarak belirlenmiştir. Oleandrinin TLR’ler (1-10) ve MYD88 genlerinin ekspresyon seviyeleri üzerindeki etkisi qPCR ile analiz edilmiştir. Oleandrin uygulaması sonucunda TLR1, TLR6 ve MYD88 genlerinin ekspresyon seviyelerinde belirgin bir azalma ile sonuçlanırken, diğer TLR’lerin ifadesi nispeten stabil kalmıştır. Sonuç olarak, oleandrin, Ishikawa kanser hücrelerinin canlılığını önemli ölçüde azaltarak, TLR1, TLR6 ve MYD88 genlerinin seviyelerinin modülasyonu yoluyla TLR sinyal yolaklarını etkileyen sitotoksik etkiler göstermiştir.
- 31 December 2025
- Published by Necmettin Erbakan University in Necmettin Erbakan Üniversitesi Fen ve Mühendislik Bilimleri Dergisi
- Vol. 7 (3) , 372-381
Oleandrin Downregulates Toll-Like Receptor Pathway Genes in Human Endometrial Carcinoma Cells
Endometrial kanser, endometriyal dokularda kötü huylu hücrelerin gelişiminden kaynaklanır ve dünya genelinde kadınlar arasında altıncı en yaygın kanser türüdür. Doğuştan gelen bağışıklık sisteminin bir bileşeni olan Toll benzeri reseptörler (TLR’ler), patojenlerin tanınmasında kritik bir işlev üstlenir. Önceki araştırmalar, TLR’ler ile farklı kanser türleri arasında bir ilişki olduğunu ve TLR ekspresyonunun kanser hücrelerinde progresyon, apoptoz ve hayatta kalma ile ilişkili olduğunu göstermiştir. Apocynaceae familyasından olan Nerium oleander L., geleneksel olarak çeşitli hastalıkların tedavisinde kullanılmıştır. N. oleander’in yaprakları ve tohumlarından elde edilen oleandrin bileşiği, çeşitli insan kanser hücrelerinin büyümesini baskıladığı gösterilmiştir. Bu çalışma, oleandrinin Ishikawa insan endometrial karsinom hücrelerinde TLR yolağı genleri üzerine etkisini incelemeyi amaçlamıştır. Oleandrin uygulamasının ardından, XTT proliferasyon testi 24., 48. ve 72. saatlerde gerçekleştirilmiştir. IC50 değeri 48. saat için 75,3 nM olarak belirlenmiştir. Oleandrinin TLR’ler (1-10) ve MYD88 genlerinin ekspresyon seviyeleri üzerindeki etkisi qPCR ile analiz edilmiştir. Oleandrin uygulaması sonucunda TLR1, TLR6 ve MYD88 genlerinin ekspresyon seviyelerinde belirgin bir azalma ile sonuçlanırken, diğer TLR’lerin ifadesi nispeten stabil kalmıştır. Sonuç olarak, oleandrin, Ishikawa kanser hücrelerinin canlılığını önemli ölçüde azaltarak, TLR1, TLR6 ve MYD88 genlerinin seviyelerinin modülasyonu yoluyla TLR sinyal yolaklarını etkileyen sitotoksik etkiler göstermiştir.
- 22 December 2025
- Published by Springer Nature in Biological Trace Element Research
- Vol. 204 (6) , 3988-3997
Boric Acid Stimulates Wound Closure and Modulates EMT-Related Gene Expression in HaCaT Cells
- 22 December 2025
- Published by Springer Nature in Biological Trace Element Research
- Vol. 204 (6) , 3988-3997
Boric Acid Stimulates Wound Closure and Modulates EMT-Related Gene Expression in HaCaT Cells
- 17 November 2025
- Published by Springer Nature in Molecular Neurobiology
- Vol. 63 (1) , 64
Targeting the Rho/ROCK Signaling Pathway Mitigates Mitochondrial Dysfunction in 6-OHDA-Induced Models of Parkinson’s Disease, Both In Vivo and In Vitro
Parkinson’s disease (PD) is a neurodegenerative disorder characterized by the progressive loss of dopaminergic neurons and has been attracting increasing attention due to its rising incidence worldwide. Given that modulating the Rho/ROCK signaling pathway presents a potential therapeutic avenue for PD, this investigation sought to elucidate the molecular mechanisms of Y-27632, a potent ROCK inhibitor, building upon prior findings. To achieve this, both in vivo and in vitro PD models were employed. We assessed mitochondrial function through mtDNA copy number, mitochondrial complex-I activity, and membrane potential. Additionally, molecular analyses examined the expression of PD-related and mitochondrial genes at both mRNA and protein levels. Biochemical assays quantified antioxidant enzyme activities, reactive oxygen species (ROS), and ATP levels. The results demonstrated that intracranial Y-27632 microinjections ameliorated 6-OHDA-induced motor deficits in rats. Notably, Y-27632 enhanced mitochondrial complex-I enzyme activity and attenuated ROS production in both in vitro and in vivo models, compared to 6-OHDA-treated groups. Furthermore, Y-27632 administration elevated antioxidant enzyme activities and increased the protein levels of TH, PINK1, UCP2, and UCP3. Consequently, these findings suggest that inhibiting the Rho/ROCK signaling cascade may exert antiparkinsonian effects by modulating mitochondrial functions.
- 17 November 2025
- Published by Springer Nature in Molecular Neurobiology
- Vol. 63 (1) , 64
Targeting the Rho/ROCK Signaling Pathway Mitigates Mitochondrial Dysfunction in 6-OHDA-Induced Models of Parkinson’s Disease, Both In Vivo and In Vitro
Parkinson’s disease (PD) is a neurodegenerative disorder characterized by the progressive loss of dopaminergic neurons and has been attracting increasing attention due to its rising incidence worldwide. Given that modulating the Rho/ROCK signaling pathway presents a potential therapeutic avenue for PD, this investigation sought to elucidate the molecular mechanisms of Y-27632, a potent ROCK inhibitor, building upon prior findings. To achieve this, both in vivo and in vitro PD models were employed. We assessed mitochondrial function through mtDNA copy number, mitochondrial complex-I activity, and membrane potential. Additionally, molecular analyses examined the expression of PD-related and mitochondrial genes at both mRNA and protein levels. Biochemical assays quantified antioxidant enzyme activities, reactive oxygen species (ROS), and ATP levels. The results demonstrated that intracranial Y-27632 microinjections ameliorated 6-OHDA-induced motor deficits in rats. Notably, Y-27632 enhanced mitochondrial complex-I enzyme activity and attenuated ROS production in both in vitro and in vivo models, compared to 6-OHDA-treated groups. Furthermore, Y-27632 administration elevated antioxidant enzyme activities and increased the protein levels of TH, PINK1, UCP2, and UCP3. Consequently, these findings suggest that inhibiting the Rho/ROCK signaling cascade may exert antiparkinsonian effects by modulating mitochondrial functions.
- 29 October 2025
- Published by Springer Nature in Medical Oncology
- Vol. 42 (12) , 1-9
Anticancer potential of chamaejasmenin B: apoptotic and antioxidant effects on pancreatic cancer cells
The aim of this study was to investigate the effect of Chamaejasmenin B (CHB), a phytochemical, on human pancreatic cancer cell line (MIA PaCa-2). CCK-8 test was performed to evaluate the cytotoxic effect of CHB. To elucidate the molecular mechanism of CHB, expression levels of important genes in the cell cycle and apoptosis pathways were evaluated by qPCR and Western blot analysis. In addition, the effects of CHB on the colony formation capacity of cells, total oxidant and total antioxidant levels were also evaluated. The IC50 dose of CHB on MIA PaCa-2 cells was found as 647 µM at 48 h. After CHB treatment in MIA PaCa-2 cells, expressions of BAX, CASP3, CASP7, CYCS, FADD, FAS, CCND2 and P53 genes were significantly increased. However, a decrease in the expressions of CDK4, CDK6, CCND1 and CCND3 genes was observed. In addition, an elevation in CASP3 and P53 protein levels and a decrease in the level of CCND1 protein were determined. CHB treatment significantly suppressed the colony formation capacity in MIA PaCa-2 cells. In addition to these, an increase in total antioxidant levels was observed. These findings suggest that CHB seems to be a promising anticancer therapeutic agent in the treatment of pancreatic cancer.
- 29 October 2025
- Published by Springer Nature in Medical Oncology
- Vol. 42 (12) , 1-9
Anticancer potential of chamaejasmenin B: apoptotic and antioxidant effects on pancreatic cancer cells
The aim of this study was to investigate the effect of Chamaejasmenin B (CHB), a phytochemical, on human pancreatic cancer cell line (MIA PaCa-2). CCK-8 test was performed to evaluate the cytotoxic effect of CHB. To elucidate the molecular mechanism of CHB, expression levels of important genes in the cell cycle and apoptosis pathways were evaluated by qPCR and Western blot analysis. In addition, the effects of CHB on the colony formation capacity of cells, total oxidant and total antioxidant levels were also evaluated. The IC50 dose of CHB on MIA PaCa-2 cells was found as 647 µM at 48 h. After CHB treatment in MIA PaCa-2 cells, expressions of BAX, CASP3, CASP7, CYCS, FADD, FAS, CCND2 and P53 genes were significantly increased. However, a decrease in the expressions of CDK4, CDK6, CCND1 and CCND3 genes was observed. In addition, an elevation in CASP3 and P53 protein levels and a decrease in the level of CCND1 protein were determined. CHB treatment significantly suppressed the colony formation capacity in MIA PaCa-2 cells. In addition to these, an increase in total antioxidant levels was observed. These findings suggest that CHB seems to be a promising anticancer therapeutic agent in the treatment of pancreatic cancer.
- 22 September 2025
- Published by Adnan Menderes University in Meandros Medical and Dental Journal
- Vol. 26 (3) , 363-373
Ameliorative effects of alpha-tocopherol and Crithmum martimum L. against hydrogen peroxide-induced toxicity on dental pulp stem cells in vitro
Objective: Tooth-bleaching agents contain peroxide and are asserted to cause cellular damage. The study aims to evaluate the effects of the application of hydrogen peroxide (HP) on dental pulp stem cells (DPSCs) in vitro and whether alpha-tocopherol (AT) and Crithmum maritimum L. (CM) have protective effects against potential damage to occur. Materials and Methods: HP, AT and CM doses applied in the experiment were determined according to the xtt analysis results. DPSCs were treated with 2 or 6 μg/mL HP, also 100 µM AT or 2 µg/mL CM followed by two doses of HP, DNA damage levels were measured using comet assay in 0, 24, 72 hours. Results: Tail length, as a indicative of dna damage increased significantly in groups that applied only HP, compared to the control group. In contrast, the tail length of the groups that applied AT and CM was significantly shorter than that only HP-treated groups. The tail intensity and tail moment averages of all groups increased significantly than the control group at all times, except the mean tail moment of CM6HP, AT2HP groups, and mean tail intensity of the CM6HP group on the 72 hour. The tail intensity and tail moment averages of 6HP groups exhibited a significant increase compared to CM and AT applied groups at all times, except the AT6HP group on the 24th hour. The averages of 2HP group demonstrated a significant increase on the 24th hour compared to CM and AT applied groups, while no significance was observed on 0 and 72nd hours. Conclusion: HP causes genotoxicity. AT and CM, however, reduce DNA damage, significantly.
- 22 September 2025
- Published by Adnan Menderes University in Meandros Medical and Dental Journal
- Vol. 26 (3) , 363-373
Ameliorative effects of alpha-tocopherol and Crithmum martimum L. against hydrogen peroxide-induced toxicity on dental pulp stem cells in vitro
Objective: Tooth-bleaching agents contain peroxide and are asserted to cause cellular damage. The study aims to evaluate the effects of the application of hydrogen peroxide (HP) on dental pulp stem cells (DPSCs) in vitro and whether alpha-tocopherol (AT) and Crithmum maritimum L. (CM) have protective effects against potential damage to occur. Materials and Methods: HP, AT and CM doses applied in the experiment were determined according to the xtt analysis results. DPSCs were treated with 2 or 6 μg/mL HP, also 100 µM AT or 2 µg/mL CM followed by two doses of HP, DNA damage levels were measured using comet assay in 0, 24, 72 hours. Results: Tail length, as a indicative of dna damage increased significantly in groups that applied only HP, compared to the control group. In contrast, the tail length of the groups that applied AT and CM was significantly shorter than that only HP-treated groups. The tail intensity and tail moment averages of all groups increased significantly than the control group at all times, except the mean tail moment of CM6HP, AT2HP groups, and mean tail intensity of the CM6HP group on the 72 hour. The tail intensity and tail moment averages of 6HP groups exhibited a significant increase compared to CM and AT applied groups at all times, except the AT6HP group on the 24th hour. The averages of 2HP group demonstrated a significant increase on the 24th hour compared to CM and AT applied groups, while no significance was observed on 0 and 72nd hours. Conclusion: HP causes genotoxicity. AT and CM, however, reduce DNA damage, significantly.
- 18 July 2025
- Published by Springer Nature in Medical Oncology
- Vol. 42 (8) , 345
Sinapic acid induces cytoplasmic stress granule formation, ER stress and apoptosis mediated anticancer activity in human endometrial cancer cell lines
This study aimed to examine the impact of molecular mechanisms in endometrial cancer cell lines (Ishikawa and HEC-1-B) treated with sinapic acid (SA), which may have effect on regulation of genes in various processes including unfolded protein response and apoptosis. The impact of SA on cell viability was assessed through the XTT assay. Expressions of genes in apoptosis and endoplasmic reticulum (ER) stress pathways were evaluated using qPCR and western blot analyses. Effects of SA on colony formation and ER structure were determined using colony assay and transmission electron microscopy (TEM) visualization. The results showed a significant upregulated expression of CASP7, CASP8, CASP9, P53, ATF6, Eif2a, HSP47, IRE1 and PERK genes in Ishikawa cells. In HEC-1-B cells, expression of CASP3, CASP8, CYCS, FAS, P53, ATF6, CALR, CHOP, Eif2a, GRP78, HSP47, IRE1 and XBP1 genes were significantly increased, however FADD levels were decreased. Western blot analysis illustrated that comparing to the control CASP9 and CASP8 protein levels were increased in Ishikawa and in HEC-1-B cell lines, respectively. SA significantly suppressed colony formation capacities in both cell lines. TEM analyses also demonstrated that SA induced cytoplasmic stress granule formation in both cell lines. Therefore, this study suggested that SA can be a potential anticancer therapeutic agent for endometrial cancer.
- 18 July 2025
- Published by Springer Nature in Medical Oncology
- Vol. 42 (8) , 345
Sinapic acid induces cytoplasmic stress granule formation, ER stress and apoptosis mediated anticancer activity in human endometrial cancer cell lines
This study aimed to examine the impact of molecular mechanisms in endometrial cancer cell lines (Ishikawa and HEC-1-B) treated with sinapic acid (SA), which may have effect on regulation of genes in various processes including unfolded protein response and apoptosis. The impact of SA on cell viability was assessed through the XTT assay. Expressions of genes in apoptosis and endoplasmic reticulum (ER) stress pathways were evaluated using qPCR and western blot analyses. Effects of SA on colony formation and ER structure were determined using colony assay and transmission electron microscopy (TEM) visualization. The results showed a significant upregulated expression of CASP7, CASP8, CASP9, P53, ATF6, Eif2a, HSP47, IRE1 and PERK genes in Ishikawa cells. In HEC-1-B cells, expression of CASP3, CASP8, CYCS, FAS, P53, ATF6, CALR, CHOP, Eif2a, GRP78, HSP47, IRE1 and XBP1 genes were significantly increased, however FADD levels were decreased. Western blot analysis illustrated that comparing to the control CASP9 and CASP8 protein levels were increased in Ishikawa and in HEC-1-B cell lines, respectively. SA significantly suppressed colony formation capacities in both cell lines. TEM analyses also demonstrated that SA induced cytoplasmic stress granule formation in both cell lines. Therefore, this study suggested that SA can be a potential anticancer therapeutic agent for endometrial cancer.
- 13 February 2025
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 101 (4) , 370-381
Anticancer activity of thymoquinone in non-small cell lung cancer and possible involvement of PPAR- γ pathway
Thymoquinone (TQ) is an ingredient of Nigella sativa and Cisplatin (CDDP) is the most active chemotherapeutic agent in lung cancer. The objective of this study was to assess the anticancer effects of TQ in non-small cell lung cancer (NSCLC) cells, and its effect on the peroxisome proliferator-activated receptor gamma (PPAR-γ) pathway. Annexin-V FITC assay was used in the NCI-H460 cell line for apoptosis. The mRNA expression of PPAR-γ, P53, BCL-2, Retinoblastoma (Rb), Cyclin-D1, RELA, Tumor necrosis Factor alpha and in a dose-dependent manner TQ activated caspases 9, 8, 7, and 3 were examined using quantitative real-time reverse transcriptase polymerase chain reaction. PPAR-γ protein levels elevated in all treatment groups, especially in the CDDP + TQ group as observed in mRNA results. In the CDDP + TQ + IR group, the reduction of NF-κB pathway, which provides survival and growth signaling, confirms the potential of this treatment in lung cancer treatment approach similar to p53, Rb, and PPAR-γ results. When the effect of treatment on the viability of NSCLC cells was assessed with flow cytometry analyzes, TQ alone supported death compared to control, cell viability also decreased in the CDDP or IR groups to which TQ was added. As a result, combined therapy of TQ, CDDP, and IR have been shown to increase apoptosis by sensitizing NSCLC cells to IR. These in vitro results are the basis because they demonstrate that it may be useful to include TQ in combined NSCLC cell treatments to reduce tumor progression.
- 13 February 2025
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 101 (4) , 370-381
Anticancer activity of thymoquinone in non-small cell lung cancer and possible involvement of PPAR- γ pathway
Thymoquinone (TQ) is an ingredient of Nigella sativa and Cisplatin (CDDP) is the most active chemotherapeutic agent in lung cancer. The objective of this study was to assess the anticancer effects of TQ in non-small cell lung cancer (NSCLC) cells, and its effect on the peroxisome proliferator-activated receptor gamma (PPAR-γ) pathway. Annexin-V FITC assay was used in the NCI-H460 cell line for apoptosis. The mRNA expression of PPAR-γ, P53, BCL-2, Retinoblastoma (Rb), Cyclin-D1, RELA, Tumor necrosis Factor alpha and in a dose-dependent manner TQ activated caspases 9, 8, 7, and 3 were examined using quantitative real-time reverse transcriptase polymerase chain reaction. PPAR-γ protein levels elevated in all treatment groups, especially in the CDDP + TQ group as observed in mRNA results. In the CDDP + TQ + IR group, the reduction of NF-κB pathway, which provides survival and growth signaling, confirms the potential of this treatment in lung cancer treatment approach similar to p53, Rb, and PPAR-γ results. When the effect of treatment on the viability of NSCLC cells was assessed with flow cytometry analyzes, TQ alone supported death compared to control, cell viability also decreased in the CDDP or IR groups to which TQ was added. As a result, combined therapy of TQ, CDDP, and IR have been shown to increase apoptosis by sensitizing NSCLC cells to IR. These in vitro results are the basis because they demonstrate that it may be useful to include TQ in combined NSCLC cell treatments to reduce tumor progression.
- Open Access
- 31 January 2025
- Published by Archives of Current Medical Research in Archives of Current Medical Research
- Vol. 6 (1) , 1-7
Mu Opioid Agonistic Effect on Neuropeptide Gene Expression Levels Involved in Hypothalamic Feeding Regulation
Background: The regulation of food intake in the hypothalamus is one of most complicated through the integration of various neuroendocrine mechanisms. In this region, orexigenic and anorexigenic peptides play a role by responding to different stimuli. Additionally, central opioidergic systems are involved in the regulation of feeding behavior. Several neuropeptides expressed in the hypothalamus also contribute to the regulation of food intake. The aim of this study was to investigate the effects of mu opioidergic agonist/antagonist molecules on both orexigenic and anorexigenic peptides gene expression levels in the hypothalamus. Methods: In our study, 48 male Wistar Albino rats were divided into 4 groups as control, morphine, naloxone and morphine+naloxone. The control group received subcutaneous SF solution for 5 days; morphine group received morphine at a dose of 10 mg/kg/day for 5 days; naloxone group SF was administered for 5 days and naloxone at a dose of 3 mg/kg 1.5 hours after the last injection: morphine+naloxone group received naloxone 1.5 hours after 5 days of morphine injection. Hypothalamus tissues were isolated from brains at the end of experimental period. Anorexigenic and orexigenic peptide expression levels were analysed by RT-PCR method. Differences between groups were statistically analyzed using one-way factorial ANOVA and Tukey post-hoc test. Results: Morphine administration results in a decrease in the expression levels of OX2R and LepR genes, but did not change ORXA, OX1R, AgRP, NPY, POMC gene expression. Naloxone administration increased AgRP and NPY expression while decreasing OX2R, LepR and APLNR gene expression levels. Conclusions: Our findings suggest that morphine may affect the gene expression of molecules related to regulation of nutrition and metabolism in the hypothalamus. Further studies are needed to clarify the possible mechanistic effects of mu opiodergic activity on the central control of feeding in morphine dependence manner.
- 31 January 2025
- Published by Archives of Current Medical Research in Archives of Current Medical Research
- Vol. 6 (1) , 1-7
Open AccessMu Opioid Agonistic Effect on Neuropeptide Gene Expression Levels Involved in Hypothalamic Feeding Regulation
Background: The regulation of food intake in the hypothalamus is one of most complicated through the integration of various neuroendocrine mechanisms. In this region, orexigenic and anorexigenic peptides play a role by responding to different stimuli. Additionally, central opioidergic systems are involved in the regulation of feeding behavior. Several neuropeptides expressed in the hypothalamus also contribute to the regulation of food intake. The aim of this study was to investigate the effects of mu opioidergic agonist/antagonist molecules on both orexigenic and anorexigenic peptides gene expression levels in the hypothalamus. Methods: In our study, 48 male Wistar Albino rats were divided into 4 groups as control, morphine, naloxone and morphine+naloxone. The control group received subcutaneous SF solution for 5 days; morphine group received morphine at a dose of 10 mg/kg/day for 5 days; naloxone group SF was administered for 5 days and naloxone at a dose of 3 mg/kg 1.5 hours after the last injection: morphine+naloxone group received naloxone 1.5 hours after 5 days of morphine injection. Hypothalamus tissues were isolated from brains at the end of experimental period. Anorexigenic and orexigenic peptide expression levels were analysed by RT-PCR method. Differences between groups were statistically analyzed using one-way factorial ANOVA and Tukey post-hoc test. Results: Morphine administration results in a decrease in the expression levels of OX2R and LepR genes, but did not change ORXA, OX1R, AgRP, NPY, POMC gene expression. Naloxone administration increased AgRP and NPY expression while decreasing OX2R, LepR and APLNR gene expression levels. Conclusions: Our findings suggest that morphine may affect the gene expression of molecules related to regulation of nutrition and metabolism in the hypothalamus. Further studies are needed to clarify the possible mechanistic effects of mu opiodergic activity on the central control of feeding in morphine dependence manner.